Genestack Press Release, 27 October 2017 “As sequencing technology shrinks to the size of a key ring and emerging technologies make it possible to track changes to the genome at single cell level, then all of a sudden genomics data becomes a streaming and wearable dataset,” says Imad Yassin, Vice President of bio data …
Written by
ndo23
Medical Advancement Institute of the Year 2017
We are privileged to receive the Medical Advancement Institute of the Year award from AI Global Media. The award is in recognition of our global alliance, which we have increased from 6 organisations in 2015 to 65 organisations in 2017. Our alliance enables partnerships between pharma, biotech, service providers and academia to convert ground-breaking science …
Milner Therapeutics Institute announces global therapeutic alliance of 65 organisations
From 6 organisations in 2015 to 65 organisations in 2017, the alliance enables partnerships between pharma, biotech, service providers and academia Cambridge, 3 October 2017 – The Milner Therapeutics Institute at the University of Cambridge announces 65 organisations are now part of their global therapeutic alliance. The alliance includes 7 pharmaceutical companies and 3 Cambridge …
Milner Symposium 2017
The Milner Therapeutics Institute Annual Symposium was held on Monday 2nd October, at West Road Concert Hall in Cambridge. The Annual Symposium is an opportunity for scientists from academia and industry to discuss the latest academic and clinical research and how it could be applied in the pharma and biotech industry to develop new treatments. …
Capella Topping Out Ceremony
The Capella Topping Out Ceremony was held on Friday (April 21), and here you can see Cambridge University Vice-Chancellor Leszek Borysiewicz finishing off the final concrete pour. The Milner Therapeutics Institute will have research laboratories within the Capella Building, which is on the Cambridge Biomedical Campus. The laboratories will be operational in 2018 and will …
Milner Therapeutics Institute announces new partnership with Elysium Health
Elysium Health joins major pharmaceutical companies to invest in collaborative research with Cambridge academic scientists through the Milner Therapeutics Consortium Cambridge, 28 March 2017 – The Milner Therapeutics Institute today announces Elysium Health as a partner to the Milner Therapeutics Consortium. Elysium Health has committed significant investment for collaborative projects with academic researchers in Cambridge over the …
Capella Time Lapse Video
https://youtu.be/gVqH_zuAAAc
New Partnership with US pharmaceutical company, Pfizer
Press Release Cambridge, 19 January 2017 – The Milner Therapeutics Institute announces Pfizer as a new partner joining the Consortium to develop mutually-beneficial collaborations with Cambridge academics and the Milner Therapeutics Institute. Pfizer joins Astex, AstraZeneca, GlaxoSmithKline, Shionogi, MedImmune and Otsuka in the Milner Therapeutics Consortium Major research investment to work with academic scientists in …
Milner Therapeutics Symposium – 17 November 2016
[et_pb_section bb_built=”1″][et_pb_row][et_pb_column type=”4_4″][et_pb_text _builder_version=”3.0.85″ background_layout=”light”] Here are some pictures from our 2016 symposium. [/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]
Milner Therapeutics Symposium – 17 November 2016
The inaugural Milner Therapeutics Symposium, From Basic Research to Drugs in Patients, was held on 17 November 2016 at St. Catharine’s College, Cambridge. Due to popular demand, talks were also live-streamed to a second venue at Homerton College. The inaugural Milner Therapeutics Symposium was an opportunity for scientists from academia and industry to discuss the …